| Location: | Texas |
|---|---|
| Posted: | Feb 12, 2025 |
| Due: | Feb 17, 2025 |
| Agency: | DEPT OF DEFENSE |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | HT942525RJLM002 |
| Publication URL: | To access bid details, please log in. |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
Request for Information (RFI)
1. RFI Number: HT9425-25-R-JLM002
2. RFI Title: Blood Plasma Spray Drying System for US Army Institute of Surgical Research (USAISR).
3. Agency: United States Army Medical Research and Development Command (USAMRDC)
4. Office: United States Army Institute of Surgical Research (USAISR)
5. Contracting Office: United States Army Medical Research Acquisition Activity (USAMRAA), Fort Detrick, Frederick, MD.
6. Location: Fort Detrick, MD
7. Synopsis: This RFI is for information and planning purposes only, at this time, and shall not be construed as a Request for Quote (RFQ) or obligation on the part of the USAMRDC. This RFI is not expected to be a RFQ or Invitation for Bid, nor does it restrict the Government to an ultimate acquisition approach. This notice is for information and planning purposes only, and is not to be construed as a commitment by the Government. The Government will not pay for solicited information. At this time, no RFQ exists; therefore, please do not request a copy of the RFQ. Telephonic inquiries will not be accepted. If an RFQ is released, a synopsis will be posted in sam.gov. It is the responsibility of any potential vendor to monitor the sam.gov website for the release of any RFQ or synopsis.
8. Background: The United States Army Institute of Surgical Research (USAISR) is part of the U.S. Army Medical Research and Development Command (USAMRDC). The USAISR is dedicated to both laboratory and clinical trauma research. Its mission is to provide requirements-driven combat casualty care medical solutions and products for injured soldiers from self-aid through definitive care across the full spectrum of military operations; provide state-of-the-art trauma, bum, and critical care to Department of Defense (DoD) beneficiaries around the world and civilians in our trauma region; and provide Burn Special Medical Augmentation Response Teams.
9. Objective and Purpose:
The Technical Requirements / Minimum Essential Characteristics (MECs) are as follows:
The USAISR seeks a blood plasma spray drying system that can be used for clinical transfusion purposes. The USAISR is seeking a spray dryer, a sealer and the plastic consumable components that are sterile-docked to blood plasma bags in a completely closed, aseptic process. The system should be able to produce a dried plasma product in bag suitable for transfusions. The system will need to be able to produce a product suitable for clinical transfusions without the need for a sterile room. System should be able to produce a spray dried unit of plasma greater than or equal to 48g.
10. Information Requested in Capability Statement:
Provide information on the ability to provide Blood Plasma Spray Drying System as listed above.
11. North American Industry Classification System (NAICS) Code: The NAICS code for this potential action is 334519 – Other Measuring and Controlling Device Manufacturing.
12. Response Due Date: Interested parties should submit the attached RFI response electronically by 12:00 pm Eastern 17 February 2025 via e-mail to Jeremy McMurry at Jeremy.l.mcmurry.civ@health.mil
13. Instructions to Responders:
13.1 The Government appreciates responses from all capable and qualified sources.
13.2 The subject header of the e-mail for submission of questions and/or the RFI response shall be: HT9425-25-R-JLM002.
13.3 Interested firms should submit a response (Capability Statement) that demonstrates the Offeror’s capabilities as they relate to the requirements identified in this RFI. The Capability Statement shall not exceed three (3) typed pages; additional sheets for cover page will not be counted toward page limitation.
13.3.1
a. Cover Page (1 page)
i. Title
ii. Organization
iii. Responders technical and administrative points of contact (names, addresses, phone, fax number and email addresses)
b. Current Technical Expertise, Knowledge, and Product Availability
i. Discussion of capabilities/challenges/technologies
ii. Technical response, demonstrate the ability to provide: Blood Plasma Spray Drying System
c. Brief summary of relevant experience pertaining to the requirement (for example: government, academia, or industry experience).
13.4 Provide the below information when responding to this Sources Sought / RFI.
RFI Number
Company Name
Company Address
Point of Contact
Phone Number
E-mail Address
Tax Identification Number (TIN)
Cage Code
Unique Entity Identifier
Company Web Page
Company Location(s)
Company is / is not a Small Business
Company is / is not SAM Registered
Other Classifications (e.g. 8(a), HubZone, Woman-Owned, Veteran-Owned, Service-Disabled Veteran-Owned)
14. Disclaimer and Important Notes: The purpose of this RFI notice is to gain market knowledge. The Government is not obligated to award a contract or otherwise pay for the information provided in the responses received. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its responses are complete and sufficiently detailed to allow the Government to determine the organization's solution. Responders are advised that the Government is under no obligation to acknowledge receipt of the information received, or to provide feedback to respondents regarding any information submitted. After a review of the responses received, a RFQ may be published in sam.gov. Responses to this notice will not be considered adequate responses to an RFQ.
15. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in submitted responses. The Government reserves the right to use any non-proprietary technical information in any resultant RFQ(s).
Original Point of Contact
POC: Jeremy McMurry, Jeremy.l.mcmurry.civ@health.mil

With GovernmentContracts, you can: